+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nuclear Medicine Instrumentation Market - Global Forecast 2026-2032- Product Image
Nuclear Medicine Instrumentation Market - Global Forecast 2026-2032- Product Image
Sale

Nuclear Medicine Instrumentation Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6116721
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Nuclear Medicine Instrumentation Market is projected to reach USD 4.81 Billion in 2026. It is expected to continue growing at a CAGR of 7.00%, reaching USD 7.25 Billion by 2032.

Nuclear Medicine Instrumentation: Executive Overview

Nuclear medicine instrumentation supports the detection, localization, characterization, and monitoring of disease through radiopharmaceutical-based imaging and associated measurement systems. The field includes gamma cameras, SPECT and PET platforms, hybrid imaging, dose-calibration equipment, radiation detectors, and workflow technologies used across clinical, research, and therapeutic environments. Its development is shaped by diagnostic accuracy, radiopharmaceutical availability, radiation safety, reimbursement conditions, installed infrastructure, and the need to improve patient throughput without compromising care quality.

Clinical Integration and Workflow Modernization Are Reshaping the Field

The landscape is shifting from standalone imaging devices toward integrated diagnostic pathways. Hybrid modalities, automated acquisition protocols, quantitative imaging, theranostic workflows, and tighter connections with radiology and oncology are increasing the importance of interoperability and standardized data. At the same time, healthcare providers are prioritizing lower-dose examinations, faster studies, simplified operation, and equipment that can support both routine and specialized applications. These changes place greater emphasis on serviceability, staff training, regulatory compliance, and lifecycle management rather than on device acquisition alone.

Artificial Intelligence Is Improving Image Quality, Quantification, and Operational Control

Artificial intelligence is being applied to image reconstruction, denoising, attenuation correction, lesion detection, segmentation, dosimetry, protocol selection, and workflow scheduling. Its cumulative impact is strongest where it helps extract clinically useful information from lower-count or motion-affected studies and supports more consistent interpretation. Adoption still depends on representative validation datasets, explainability, cybersecurity, regulatory clearance, integration with clinical systems, and clear accountability for clinical decisions. Leaders should therefore treat AI as an augmentation layer within governed workflows, not as a substitute for expert oversight.

Regional Insights: Infrastructure Maturity Coexists With Uneven Access

North America is characterized by advanced hybrid imaging, established nuclear medicine services, and strong emphasis on clinical productivity, interoperability, and evidence generation. Europe combines sophisticated imaging capabilities with varied national procurement, reimbursement, and regulatory environments. Asia-Pacific includes highly developed systems in countries such as Japan, South Korea, and Australia alongside rapidly expanding capacity and infrastructure-development needs elsewhere. Latin America is influenced by uneven equipment distribution, radiopharmaceutical logistics, and public-private differences in access. The Middle East is investing in specialized healthcare capacity and advanced diagnostics, while workforce development and supply continuity remain important. Africa presents substantial unmet infrastructure and training needs, with centralized services, partnerships, and resilient maintenance models particularly relevant.

Group Insights: Cooperation, Regulation, and Supply Resilience Shape Adoption

ASEAN countries show diverse levels of nuclear medicine infrastructure, making regional training, referral networks, and harmonized procurement useful for expanding access. BRICS members combine large and varied healthcare systems with differing domestic manufacturing, research, and regulatory capabilities. The European Union is shaped by cross-border standards, coordinated regulation, and national differences in reimbursement and service provision. G7 healthcare systems generally emphasize advanced imaging, clinical evidence, data governance, and replacement planning. GCC countries are strengthening specialized healthcare capacity and may benefit from centralized expertise, shared services, and robust radiopharmaceutical logistics. NATO members span mature and developing health systems, making interoperability, emergency preparedness, and supply-chain resilience relevant considerations.

Country Insights: National Priorities Determine Technology Pathways

Australia emphasizes geographically distributed care, workforce capability, and reliable access across remote populations. Brazil’s priorities include expanding specialized services while addressing regional disparities and infrastructure constraints. Canada places importance on equitable access across a large geography, coordinated procurement, and capacity planning. China is advancing domestic healthcare and technology capabilities while expanding sophisticated imaging services. France and Germany combine established nuclear medicine practice with strong regulatory, reimbursement, and quality requirements. India is balancing rapid clinical demand with affordability, regional access, and workforce development. Italy and Spain are focused on modernization within publicly oriented health systems, while the United Kingdom emphasizes evidence-based adoption, service efficiency, and national coordination. Japan has extensive experience with nuclear medicine and continues to pursue workflow and imaging improvements. South Korea combines advanced digital healthcare capabilities with specialized diagnostic infrastructure. Mexico is addressing uneven access and the need for dependable service networks. Russia’s environment is influenced by domestic capability, infrastructure variation, and supply continuity. The United States remains focused on advanced hybrid imaging, clinical integration, productivity, and regulatory governance.

Action Priorities for Leaders: Build Interoperable, Resilient, and Clinically Governed Systems

Industry leaders should prioritize platforms that integrate with electronic health records, radiology information systems, PACS, dose-management tools, and radiopharmaceutical workflows. Procurement decisions should assess total lifecycle performance, uptime, service coverage, cybersecurity, upgradeability, and staff usability rather than acquisition specifications alone. Organizations should establish evidence-based AI governance, including local validation, bias monitoring, human review, and post-deployment performance tracking. Regional partnerships can strengthen training, referral pathways, maintenance, and isotope logistics, particularly where services are concentrated in major urban centers. Finally, leaders should align technology planning with radiation-safety programs, standardized protocols, patient-centered scheduling, and transparent clinical outcome measurement.

Research Methodology: Evidence-Based Synthesis of Technology, Care, and Infrastructure Factors

This executive summary uses a structured qualitative assessment of nuclear medicine instrumentation across clinical applications, technology evolution, healthcare infrastructure, regulation, workforce, radiopharmaceutical logistics, and regional access conditions. The analysis organizes findings by region, multinational grouping, and country to distinguish shared patterns from local priorities. It emphasizes verifiable industry and healthcare-system characteristics, avoids unsupported numerical claims, and interprets artificial intelligence in relation to validated clinical use, workflow integration, governance, and safety. Conclusions are framed as strategic implications rather than market estimates or forecasts.

Conclusion: Sustainable Progress Depends on Integrated Capability

Nuclear medicine instrumentation is advancing through the convergence of hybrid imaging, quantitative analysis, automation, radiopharmaceutical innovation, and artificial intelligence. The most durable progress will come from integrating equipment with dependable supply chains, skilled personnel, interoperable information systems, rigorous safety practices, and clinically validated workflows. Because regional and national conditions differ substantially, successful strategies will combine common technical standards with flexible deployment models. Leaders that connect innovation to measurable clinical value, operational resilience, and equitable access will be best positioned to strengthen nuclear medicine services.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Nuclear Medicine Instrumentation Market, by Technology
7.1. Introduction
7.2. Hybrid Imaging
7.2.1. PET/CT Systems
7.2.2. SPECT/CT Systems
7.3. Positron Emission Tomography
7.4. Single Photon Emission Computed Tomography
8. Nuclear Medicine Instrumentation Market, by Product Category
8.1. Introduction
8.2. Diagnostic Instruments
8.3. Therapeutic Instruments & Radiopharmaceuticals
9. Nuclear Medicine Instrumentation Market, by Application
9.1. Introduction
9.2. Cardiology
9.3. Neurology
9.4. Oncology
10. Nuclear Medicine Instrumentation Market, by End User
10.1. Introduction
10.2. Diagnostic Imaging Centers
10.3. Hospitals
10.4. Research Institutes
11. Nuclear Medicine Instrumentation Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Nuclear Medicine Instrumentation Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Nuclear Medicine Instrumentation Market, by Country
13.1. Introduction
13.2. United States
13.3. China
13.4. Germany
13.5. United Kingdom
13.6. India
13.7. Japan
13.8. Russia
13.9. Brazil
13.10. Canada
13.11. Italy
13.12. Mexico
13.13. France
13.14. Spain
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. AMETEK Inc.
15.2. B J Madan & Co
15.3. Berthold Technologies GmbH & Co.KG
15.4. Blue Earth Diagnostics
15.5. Bruker Corporation
15.6. Canon Medical Systems Corporation
15.7. Cardinal Health
15.8. COMECER SpA
15.9. Digirad
15.10. Exosens
15.11. GE Healthcare
15.12. Geebee International
15.13. Hidex Oy
15.14. Ion Beam Applications S.A.
15.15. Jubilant DraxImage, Inc.
15.16. Koninklijke Philips N.V.
15.17. Mediso Medical Imaging Systems, Inc.
15.18. Mirion Technologies, Inc.
15.19. Neusoft Medical Systems Co., Ltd.
15.20. Nucleonix Systems (P) Ltd.
15.21. Nucleuz Healthcare Pvt Ltd
15.22. NUVIATech Healthcare
15.23. OVIS Imaging Solutions
15.24. PerkinElmer, Inc.
15.25. Radiation Monitoring Devices
15.26. Rotem Industries Ltd.
15.27. Siemens Healthineers AG
15.28. Spectrum Dynamics Medical Ltd.
15.29. Spectrum Instrumentation
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Nuclear Medicine Instrumentation Market, Years Considered for the Study
FIGURE 2. Global Nuclear Medicine Instrumentation Market, Research Design
FIGURE 3. Global Nuclear Medicine Instrumentation Market, Research Framework
FIGURE 4. Global Nuclear Medicine Instrumentation Market, Data Triangulation
FIGURE 5. Global Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Nuclear Medicine Instrumentation Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Nuclear Medicine Instrumentation Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Nuclear Medicine Instrumentation Market Size, by Product Category, 2025 vs 2032 (%)
FIGURE 9. Global Nuclear Medicine Instrumentation Market Size, by Product Category, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Nuclear Medicine Instrumentation Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Nuclear Medicine Instrumentation Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Nuclear Medicine Instrumentation Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Nuclear Medicine Instrumentation Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Nuclear Medicine Instrumentation Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Nuclear Medicine Instrumentation Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Nuclear Medicine Instrumentation Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Nuclear Medicine Instrumentation Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Nuclear Medicine Instrumentation Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Nuclear Medicine Instrumentation Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Nuclear Medicine Instrumentation Market Segmentation & Coverage
TABLE 2. Global Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 3. Global Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Hybrid Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Hybrid Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Hybrid Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global PET/CT Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global PET/CT Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global PET/CT Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global SPECT/CT Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global SPECT/CT Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global SPECT/CT Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Positron Emission Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Positron Emission Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Positron Emission Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Single Photon Emission Computed Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Single Photon Emission Computed Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Single Photon Emission Computed Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 20. Global Diagnostic Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Diagnostic Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Diagnostic Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Therapeutic Instruments & Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Therapeutic Instruments & Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Therapeutic Instruments & Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 27. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 37. Global Diagnostic Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Diagnostic Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Diagnostic Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Nuclear Medicine Instrumentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Asia-Pacific Nuclear Medicine Instrumentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Asia-Pacific Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 49. Asia-Pacific Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 53. North America Nuclear Medicine Instrumentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. North America Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 55. North America Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 56. North America Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 57. North America Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 58. North America Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 59. Latin America Nuclear Medicine Instrumentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Latin America Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 61. Latin America Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 62. Latin America Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 63. Latin America Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. Latin America Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 65. Europe Nuclear Medicine Instrumentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Europe Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 67. Europe Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 68. Europe Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 69. Europe Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 70. Europe Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Middle East Nuclear Medicine Instrumentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Middle East Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 73. Middle East Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 74. Middle East Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 75. Middle East Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. Middle East Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Africa Nuclear Medicine Instrumentation Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Africa Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 79. Africa Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 80. Africa Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 81. Africa Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 82. Africa Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Global Nuclear Medicine Instrumentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. ASEAN Nuclear Medicine Instrumentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. ASEAN Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 86. ASEAN Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 87. ASEAN Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 88. ASEAN Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. ASEAN Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. GCC Nuclear Medicine Instrumentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. GCC Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 92. GCC Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 93. GCC Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 94. GCC Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. GCC Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. European Union Nuclear Medicine Instrumentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. European Union Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 98. European Union Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 99. European Union Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 100. European Union Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 101. European Union Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. BRICS Nuclear Medicine Instrumentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. BRICS Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 104. BRICS Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 105. BRICS Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 106. BRICS Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. BRICS Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. G7 Nuclear Medicine Instrumentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. G7 Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 110. G7 Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 111. G7 Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 112. G7 Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. G7 Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. NATO Nuclear Medicine Instrumentation Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. NATO Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 116. NATO Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 117. NATO Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 118. NATO Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. NATO Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. Global Nuclear Medicine Instrumentation Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. United States Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 122. United States Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 123. United States Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 124. United States Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 125. United States Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. United States Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. China Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 128. China Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 129. China Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 130. China Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 131. China Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. China Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Germany Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 134. Germany Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 135. Germany Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 136. Germany Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 137. Germany Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. Germany Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. United Kingdom Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 140. United Kingdom Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 141. United Kingdom Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 142. United Kingdom Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 143. United Kingdom Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. United Kingdom Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. India Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 146. India Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 147. India Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 148. India Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 149. India Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. India Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. Japan Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 152. Japan Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 153. Japan Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 154. Japan Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 155. Japan Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. Japan Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Russia Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 158. Russia Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 159. Russia Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 160. Russia Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 161. Russia Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Russia Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. Brazil Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 164. Brazil Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 165. Brazil Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 166. Brazil Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 167. Brazil Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. Brazil Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. Canada Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 170. Canada Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 171. Canada Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 172. Canada Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 173. Canada Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Canada Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Italy Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 176. Italy Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 177. Italy Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 178. Italy Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 179. Italy Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. Italy Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Mexico Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 182. Mexico Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 183. Mexico Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 184. Mexico Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 185. Mexico Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Mexico Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. France Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 188. France Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 189. France Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 190. France Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 191. France Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. France Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Spain Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 194. Spain Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 195. Spain Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 196. Spain Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 197. Spain Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. Spain Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Australia Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 200. Australia Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 201. Australia Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 202. Australia Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 203. Australia Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. Australia Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. South Korea Nuclear Medicine Instrumentation Market Size, 2017-2032 (USD Million)
TABLE 206. South Korea Nuclear Medicine Instrumentation Market Size, by Technology, 2017-2032 (USD Million)
TABLE 207. South Korea Nuclear Medicine Instrumentation Market Size, by Hybrid Imaging, 2017-2032 (USD Million)
TABLE 208. South Korea Nuclear Medicine Instrumentation Market Size, by Product Category, 2017-2032 (USD Million)
TABLE 209. South Korea Nuclear Medicine Instrumentation Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. South Korea Nuclear Medicine Instrumentation Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. Global Nuclear Medicine Instrumentation Market Share, by Key Player, 2025
TABLE 212. Global Nuclear Medicine Instrumentation Market, Key Experts

Companies Mentioned

  • AMETEK Inc.
  • B J Madan & Co
  • Berthold Technologies GmbH & Co.KG
  • Blue Earth Diagnostics
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Cardinal Health
  • COMECER SpA
  • Digirad
  • Exosens
  • GE Healthcare
  • Geebee International
  • Hidex Oy
  • Ion Beam Applications S.A.
  • Jubilant DraxImage, Inc.
  • Koninklijke Philips N.V.
  • Mediso Medical Imaging Systems, Inc.
  • Mirion Technologies, Inc.
  • Neusoft Medical Systems Co., Ltd.
  • Nucleonix Systems (P) Ltd.
  • Nucleuz Healthcare Pvt Ltd
  • NUVIATech Healthcare
  • OVIS Imaging Solutions
  • PerkinElmer, Inc.
  • Radiation Monitoring Devices
  • Rotem Industries Ltd.
  • Siemens Healthineers AG
  • Spectrum Dynamics Medical Ltd.
  • Spectrum Instrumentation

Related Topics

Related Reports

Radioisotopes Labeling Services Market - Global Forecast 2026-2032 - Product Image

Radioisotopes Labeling Services Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2026-2032 - Product Image

Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Radiopharmaceuticals Market Report by Product Type, Application, End Use, and Region 2026-2034 - Product Image

Radiopharmaceuticals Market Report by Product Type, Application, End Use, and Region 2026-2034

  • Report
  • 147 Pages
  • Global
From
Nuclear Medicine Radioisotope - Global Strategic Business Report - Product Image

Nuclear Medicine Radioisotope - Global Strategic Business Report

  • Report
  • 186 Pages
  • Global
From
Nuclear Medicine Equipment Market Report by Product, Application, End User, and Region 2026-2034 - Product Image

Nuclear Medicine Equipment Market Report by Product, Application, End User, and Region 2026-2034

  • Report
  • 136 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.